Blog
Month: November 2021

Preparing for Cell and Gene Therapy 3.0

Blog

Patient data is mission-critical data — especially in cell and gene therapy.

In cell and gene therapy (CGT), the patient is the process is the…

Must-watch: Vineti’s Women in Tech panel discussion

Blog

ers across healthcare and technology! The event was moderated by Kat Noren, SVP of People and Places at Vineti, with panelists including Heidi Rozen, Partner…

Patient data – the unique role in cell and gene therapies (CGTs)

Blog

Patient data is mission-critical data — especially in cell and gene therapy.

In cell and gene therapy (CGT), the patient is the process is the…

Patient data – why it is critical for cell and gene therapy stakeholders

Blog

The first blog post in this series provided an overview of how the advanced therapies supply chain is different from traditional and biologic drug products…

Patient data – unique challenges, critical uses in the cell therapy value chain

Blog

The previous two blog posts in this series provided an overview of why patient-related data matters in cell therapy and gene therapy (CGTs), and how…

Integrated patient data – the future of advanced therapies

Blog

The cell and gene therapy (CGT) sector is poised for exponential growth — which will come in novel ways that reflect the unique nature of…